{
    "clinical_study": {
        "@rank": "1414", 
        "arm_group": {
            "arm_group_label": "NG PROMUS stent", 
            "arm_group_type": "Experimental", 
            "description": "Single-arm treatment group receiving interventional NG PROMUS study stent"
        }, 
        "brief_summary": {
            "textblock": "NG PROMUS: A Prospective, Multicenter Trial to Assess the NG PROMUS Everolimus-Eluting\n      Platinum Chromium Coronary Stent System (NG PROMUS Stent System) for the Treatment of\n      Atherosclerotic Lesion(s)"
        }, 
        "brief_title": "NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": {
                        "@group_id": "B1", 
                        "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                        "title": "NG PROMUS Stent"
                    }
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "100"
                                        }
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@spread": "9.73", 
                                            "@value": "61.72"
                                        }
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age, Customized", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "15"
                                            }
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "85"
                                            }
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "2"
                                            }
                                        }, 
                                        "sub_title": "Hispanic or Latino"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "72"
                                            }
                                        }, 
                                        "sub_title": "Caucasian"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "13"
                                            }
                                        }, 
                                        "sub_title": "Asian"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "1"
                                            }
                                        }, 
                                        "sub_title": "Black, of African Heritage"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "5"
                                            }
                                        }, 
                                        "sub_title": "Native Hawaiian or Other Pacific Islander"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "6"
                                            }
                                        }, 
                                        "sub_title": "Other"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "1"
                                            }
                                        }, 
                                        "sub_title": "Not disclosed"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Race/Ethnicity, Customized", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "10"
                                            }
                                        }, 
                                        "sub_title": "Singapore"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "2"
                                            }
                                        }, 
                                        "sub_title": "Australia"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "88"
                                            }
                                        }, 
                                        "sub_title": "New Zealand"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "23"
                                            }
                                        }, 
                                        "sub_title": "Previous Percutaneous Coronary Intervention"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "5"
                                            }
                                        }, 
                                        "sub_title": "Previous Coronary Artery Bypass Graft"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "16"
                                            }
                                        }, 
                                        "sub_title": "Previous Myocardial Infarction"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "2"
                                            }
                                        }, 
                                        "sub_title": "Congestive Heart Failure"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "51"
                                            }
                                        }, 
                                        "sub_title": "Stable Angina"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "25"
                                            }
                                        }, 
                                        "sub_title": "Unstable Angina"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "7"
                                            }
                                        }, 
                                        "sub_title": "Silent Ischemia"
                                    }
                                ]
                            }, 
                            "description": "Note: A single participant could potentially experience multiple categories listed below.", 
                            "param": "Number", 
                            "title": "Cardiac History", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "56"
                                            }
                                        }, 
                                        "sub_title": "Smoking, Ever"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "16"
                                            }
                                        }, 
                                        "sub_title": "Medically Treated Diabetes"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "78"
                                            }
                                        }, 
                                        "sub_title": "Hyperlipidemia Requiring Medication"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "70"
                                            }
                                        }, 
                                        "sub_title": "Hypertension Requiring Medication"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "51"
                                            }
                                        }, 
                                        "sub_title": "Family History of Coronary Artery Disease"
                                    }
                                ]
                            }, 
                            "description": "Note: A single participant could potentially experience multiple categories listed below.", 
                            "param": "Number", 
                            "title": "Cardiac Risk Factors", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "60"
                                            }
                                        }, 
                                        "sub_title": "Left Anterior Descending Artery"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "27"
                                            }
                                        }, 
                                        "sub_title": "Circumflex Artery"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "32"
                                            }
                                        }, 
                                        "sub_title": "Right Coronary Artery"
                                    }
                                ]
                            }, 
                            "description": "Note: A single participant could potentially experience multiple categories listed below.", 
                            "param": "Number", 
                            "title": "Lesion Characteristics: Target Lesion Vessel", 
                            "units": "Lesions"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "8"
                                            }
                                        }, 
                                        "sub_title": "Ostial"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "47"
                                            }
                                        }, 
                                        "sub_title": "Proximal"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "49"
                                            }
                                        }, 
                                        "sub_title": "Mid"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "15"
                                            }
                                        }, 
                                        "sub_title": "Distal"
                                    }
                                ]
                            }, 
                            "description": "Note: A single participant could potentially experience multiple categories listed below.", 
                            "param": "Number", 
                            "title": "Lesion Characteristic: Lesion Location", 
                            "units": "Lesions"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "91"
                                            }
                                        }, 
                                        "sub_title": "Less than or equal to 20 mm"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "28"
                                            }
                                        }, 
                                        "sub_title": "Greater than 20 mm"
                                    }
                                ]
                            }, 
                            "description": "Note: A single participant could potentially experience multiple categories listed below.", 
                            "param": "Number", 
                            "title": "Lesion Characteristic: Lesion Length", 
                            "units": "Lesions"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "10"
                                            }
                                        }, 
                                        "sub_title": "Tortuosity, Any"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "35"
                                            }
                                        }, 
                                        "sub_title": "Calcification, Any"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "3"
                                            }
                                        }, 
                                        "sub_title": "Ulcerated"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "2"
                                            }
                                        }, 
                                        "sub_title": "Aneurysm"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "61"
                                            }
                                        }, 
                                        "sub_title": "Bifurcation"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "2"
                                            }
                                        }, 
                                        "sub_title": "Total Occlusion"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "86"
                                            }
                                        }, 
                                        "sub_title": "Eccentric Lesion"
                                    }
                                ]
                            }, 
                            "description": "Note: A single participant could potentially experience multiple categories listed below.", 
                            "param": "Number", 
                            "title": "Lesion Characteristics", 
                            "units": "Lesions"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": "0 (no perfusion)"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "2"
                                            }
                                        }, 
                                        "sub_title": "1 (penetration with minimal perfusion)"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "9"
                                            }
                                        }, 
                                        "sub_title": "2 (partial perfusion)"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "108"
                                            }
                                        }, 
                                        "sub_title": "3 (complete perfusion)"
                                    }
                                ]
                            }, 
                            "description": "Note: A single participant could potentially experience multiple categories listed below.", 
                            "param": "Number", 
                            "title": "Lesion Characteristic: Pre-Procedure Thrombolysis in Myocardial Infarction (TIMI) Flow", 
                            "units": "Lesions"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@spread": "0.45", 
                                                "@value": "2.78"
                                            }
                                        }, 
                                        "sub_title": "Reference Vessel Diameter"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@spread": "0.29", 
                                                "@value": "0.85"
                                            }
                                        }, 
                                        "sub_title": "Minimum Lumen Diameter"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@spread": "7.14", 
                                                "@value": "16.05"
                                            }
                                        }, 
                                        "sub_title": "Lesion Length"
                                    }
                                ]
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Lesion Characteristics by Quantitative Cornary Angiography", 
                            "units": "Millimeters"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@spread": "9.69", 
                                            "@value": "69.12"
                                        }
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Lesion Characteristic: Percent Diameter Stenosis by QCA", 
                            "units": "Percent Diameter Stenosis"
                        }
                    ]
                }, 
                "population": "Single arm with investigational NG PROMUS Everolimus Eluting Coronary Stent System\nN=100 patients, N=119 Lesions, N=127 Stents"
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "Institution and Investigator shall have the right to publish the results, provided that before publishing, Institution and Investigator shall submit copies of any proposed publication or presentation to Sponsor for review at least sixty (60) days in advance of submission for publication or presentation to a publisher or other third party. Sponsor reserves the right to delete any confidential information or other proprietary information of Sponsor from the proposed publication or presentation."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "description": "Technical success is defined as successful delivery and deployment of the study stent to the target lesion, without balloon rupture or stent embolization, and post-procedure diameter stenosis of <30% assessed in 2 near-orthogonal projections with TIMI 3 flow in the target lesion, as visually assessed by the physician", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "119"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Lesions analyzed", 
                                    "units": "Lesions"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@lower_limit": "95.4", 
                                                    "@upper_limit": "100", 
                                                    "@value": "99.2"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Technical success is defined as successful delivery and deployment of the study stent to the target lesion, without balloon rupture or stent embolization, and post-procedure diameter stenosis of <30% assessed in 2 near-orthogonal projections with TIMI 3 flow in the target lesion, as visually assessed by the physician", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Number", 
                                    "title": "Technical Success Rate", 
                                    "units": "percentage of lesions"
                                }
                            ]
                        }, 
                        "safety_issue": "Yes", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day", 
                        "title": "Technical Success Rate", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Target lesion revascularization is any ischemia-driven repeat percutaneous intervention, to improve blood flow, of the successfully treated target lesion or bypass surgery of the target vessel with a graft distally to the successfully treated target lesion. A TLR will be considered as ischemia-driven if the target lesion diameter stenosis is >/= 50% by QCA and there is presence of clinical or functional ischemia which cannot be explained by other coronary or graft lesions. Clinical or functional ischemia is any of the following:\nThe subject has a positive functional study corresponding to the area served by the target lesion.\nThe subject has ischemic ECG changes at rest in a distribution consistent with the target vessel.\nThe subject has ischemic symptoms referable to the target lesion. A TLR will be considered as ischemia-driven if the lesion diameter stenosis is >/= 70% by QCA even in the absence of clinical or functional ischemia.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "0"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Target lesion revascularization is any ischemia-driven repeat percutaneous intervention, to improve blood flow, of the successfully treated target lesion or bypass surgery of the target vessel with a graft distally to the successfully treated target lesion. A TLR will be considered as ischemia-driven if the target lesion diameter stenosis is >/= 50% by QCA and there is presence of clinical or functional ischemia which cannot be explained by other coronary or graft lesions. Clinical or functional ischemia is any of the following:\nThe subject has a positive functional study corresponding to the area served by the target lesion.\nThe subject has ischemic ECG changes at rest in a distribution consistent with the target vessel.\nThe subject has ischemic symptoms referable to the target lesion. A TLR will be considered as ischemia-driven if the lesion diameter stenosis is >/= 70% by QCA even in the absence of clinical or functional ischemia.", 
                                    "param": "Number", 
                                    "title": "Target Lesion Revascularization (TLR) Rate", 
                                    "units": "percentage of participants"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day and at 30 days", 
                        "title": "Target Lesion Revascularization (TLR) Rate", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Target lesion failure is any ischemia-driven revascularization of the target lesion, MI (Q-wave and non\u2013Q-wave) related to the target vessel, or (cardiac) death. For the purposes of this protocol, if it cannot be determined with certainty whether the MI was related to the target vessel, it will be considered a TLF.\nThe MI definition used for Target Lesion Failure was the PLATINUM MI definition.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "2"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Target lesion failure is any ischemia-driven revascularization of the target lesion, MI (Q-wave and non\u2013Q-wave) related to the target vessel, or (cardiac) death. For the purposes of this protocol, if it cannot be determined with certainty whether the MI was related to the target vessel, it will be considered a TLF.\nThe MI definition used for Target Lesion Failure was the PLATINUM MI definition.", 
                                    "param": "Number", 
                                    "title": "Target Lesion Failure (TLF) Rate", 
                                    "units": "percentage of participants"
                                }
                            ]
                        }, 
                        "safety_issue": "Yes", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day and at 30 days", 
                        "title": "Target Lesion Failure (TLF) Rate", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Target vessel revascularization is defined as a TLR or a TVR remote. Target vessel revascularization remote is any ischemia-driven repeat percutaneous intervention, to improve blood flow, or bypass surgery of not previously existing lesions diameter stenosis >/= 50% by QCA in the target vessel, excluding the target lesion. A TVR will be considered ischemia-driven if the target vessel diameter stenosis is >/= 50% by QCA and any of the following are present:\nThe subject has a positive functional study corresponding to the area served by the target vessel.\nThe subject has ischemic ECG changes at rest in a distribution consistent with the target vessel.\nThe subject has ischemic symptoms referable to the target vessel. A TVR will also be considered as ischemia-driven if the lesion diameter stenosis is >/=70% even in the absence of clinical or functional ischemia.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "0"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Target vessel revascularization is defined as a TLR or a TVR remote. Target vessel revascularization remote is any ischemia-driven repeat percutaneous intervention, to improve blood flow, or bypass surgery of not previously existing lesions diameter stenosis >/= 50% by QCA in the target vessel, excluding the target lesion. A TVR will be considered ischemia-driven if the target vessel diameter stenosis is >/= 50% by QCA and any of the following are present:\nThe subject has a positive functional study corresponding to the area served by the target vessel.\nThe subject has ischemic ECG changes at rest in a distribution consistent with the target vessel.\nThe subject has ischemic symptoms referable to the target vessel. A TVR will also be considered as ischemia-driven if the lesion diameter stenosis is >/=70% even in the absence of clinical or functional ischemia.", 
                                    "param": "Number", 
                                    "title": "Target Vessel Revascularization (TVR) Rate", 
                                    "units": "percentage of participants"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day and at 30 days", 
                        "title": "Target Vessel Revascularization (TVR) Rate", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Target vessel failure is any ischemia-driven revascularization of the target vessel, MI (Q-wave and non\u2013Q-wave) related to the target vessel or death related to the target vessel. For the purposes of this protocol, if it cannot be determined with certainty whether the MI or death was related to the target vessel, it will be considered a TVF.\nThe MI definition used was the PLATINUM MI definition.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "2"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Target vessel failure is any ischemia-driven revascularization of the target vessel, MI (Q-wave and non\u2013Q-wave) related to the target vessel or death related to the target vessel. For the purposes of this protocol, if it cannot be determined with certainty whether the MI or death was related to the target vessel, it will be considered a TVF.\nThe MI definition used was the PLATINUM MI definition.", 
                                    "param": "Number", 
                                    "title": "Target Vessel Failure (TVF) Rate", 
                                    "units": "percentage of participants"
                                }
                            ]
                        }, 
                        "safety_issue": "Yes", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day and at 30 days", 
                        "title": "Target Vessel Failure (TVF) Rate", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "MI will be defined according to the PLATINUM Definition of MI with evidence pre-specified for i) Spontaneous, ii) PCI-related, iii) CABG related, and iv) autopsy evidence criteria.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "1"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "MI will be defined according to the PLATINUM Definition of MI with evidence pre-specified for i) Spontaneous, ii) PCI-related, iii) CABG related, and iv) autopsy evidence criteria.", 
                                    "param": "Number", 
                                    "title": "Myocardial Infarction (MI, Q-wave and Non-Q-wave) Rate", 
                                    "units": "percentage of participants"
                                }
                            ]
                        }, 
                        "safety_issue": "Yes", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day and at 30 days", 
                        "title": "Myocardial Infarction (MI, Q-wave and Non-Q-wave) Rate", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Cardiac death is defined as death due to any of the following.\nAcute MI\nCardiac perforation/pericardial tamponade\nArrhythmia or conduction abnormality\nCVA through hospital discharge or CVA suspected of being related to the procedure\nDeath due to complication of the procedure, including bleeding, vascular repair, transfusion reaction, or bypass surgery\nAny death in which a cardiac cause cannot be excluded", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "1"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Cardiac death is defined as death due to any of the following.\nAcute MI\nCardiac perforation/pericardial tamponade\nArrhythmia or conduction abnormality\nCVA through hospital discharge or CVA suspected of being related to the procedure\nDeath due to complication of the procedure, including bleeding, vascular repair, transfusion reaction, or bypass surgery\nAny death in which a cardiac cause cannot be excluded", 
                                    "param": "Number", 
                                    "title": "Cardiac Death Rate", 
                                    "units": "percentage of participants"
                                }
                            ]
                        }, 
                        "safety_issue": "Yes", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day and at 30 days", 
                        "title": "Cardiac Death Rate", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Non-cardiac death is defined as a death not due to any of the following:\nAcute MI\nCardiac perforation/pericardial tamponade\nArrhythmia or conduction abnormality\nCVA through hospital discharge or CVA suspected of being related to the procedure\nDeath due to complication of the procedure, including bleeding, vascular repair, transfusion reaction, or bypass surgery\nAny death in which a cardiac cause cannot be excluded", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "0"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Non-cardiac death is defined as a death not due to any of the following:\nAcute MI\nCardiac perforation/pericardial tamponade\nArrhythmia or conduction abnormality\nCVA through hospital discharge or CVA suspected of being related to the procedure\nDeath due to complication of the procedure, including bleeding, vascular repair, transfusion reaction, or bypass surgery\nAny death in which a cardiac cause cannot be excluded", 
                                    "param": "Number", 
                                    "title": "Non-cardiac Death Rate", 
                                    "units": "percentage of participants"
                                }
                            ]
                        }, 
                        "safety_issue": "Yes", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day and at 30 days", 
                        "title": "Non-cardiac Death Rate", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Death is categorized as cardiac or non-cardiac deaths.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "1"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Death is categorized as cardiac or non-cardiac deaths.", 
                                    "param": "Number", 
                                    "title": "All Death Rate", 
                                    "units": "percentage of participants"
                                }
                            ]
                        }, 
                        "safety_issue": "Yes", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day and at 30 days", 
                        "title": "All Death Rate", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Any cardiac death or MI event meeting the criteria defined for a cardiac death or MI.\nMI definition used was the PLATINUM definition for MI.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "2"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Any cardiac death or MI event meeting the criteria defined for a cardiac death or MI.\nMI definition used was the PLATINUM definition for MI.", 
                                    "param": "Number", 
                                    "title": "Cardiac Death or MI Rate", 
                                    "units": "percentage of participants"
                                }
                            ]
                        }, 
                        "safety_issue": "Yes", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day and at 30 days", 
                        "title": "Cardiac Death or MI Rate", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Any all-cause mortality event or MI meeting the criteria defined for any death or MI.\nMI definition used was the PLATINUM definition for MI.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "2"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Any all-cause mortality event or MI meeting the criteria defined for any death or MI.\nMI definition used was the PLATINUM definition for MI.", 
                                    "param": "Number", 
                                    "title": "All Death or MI Rate", 
                                    "units": "percentage of participants"
                                }
                            ]
                        }, 
                        "safety_issue": "Yes", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day and at 30 days", 
                        "title": "All Death or MI Rate", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Any event meeting the pre-specified criteria for any death, MI, or TVR.\nMI definition used was the PLATINUM definition for MI.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "2"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Any event meeting the pre-specified criteria for any death, MI, or TVR.\nMI definition used was the PLATINUM definition for MI.", 
                                    "param": "Number", 
                                    "title": "All Death/MI/TVR Rate", 
                                    "units": "percentage of participants"
                                }
                            ]
                        }, 
                        "safety_issue": "Yes", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day and at 30 days", 
                        "title": "All Death/MI/TVR Rate", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Stent thrombosis should be reported as a cumulative value at the different time points and with the different separate time points. Time 0 is defined as the time point after the guide catheter has been removed and the patient left the catheterization lab.\nTiming:\nAcute stent thrombosis*: 0 24 hours after stent implantation\nSubacute stent thrombosis*: >24 hours to 30 days after stent implantation\nLate stent thrombosis: >30 days to 1 year after stent implantation\nVery late stent thrombosis: >1 year after stent implantation * Acute/subacute can also be replaced by early stent thrombosis. Early stent thrombosis is 0 30 days.\nStent thrombosis may be defined as:\nConfirmed/definite\nProbable\nPossible\nConfirmed/Definite (is considered either angiographic confirmed or pathologic confirmed)", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "0"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Stent thrombosis should be reported as a cumulative value at the different time points and with the different separate time points. Time 0 is defined as the time point after the guide catheter has been removed and the patient left the catheterization lab.\nTiming:\nAcute stent thrombosis*: 0 24 hours after stent implantation\nSubacute stent thrombosis*: >24 hours to 30 days after stent implantation\nLate stent thrombosis: >30 days to 1 year after stent implantation\nVery late stent thrombosis: >1 year after stent implantation * Acute/subacute can also be replaced by early stent thrombosis. Early stent thrombosis is 0 30 days.\nStent thrombosis may be defined as:\nConfirmed/definite\nProbable\nPossible\nConfirmed/Definite (is considered either angiographic confirmed or pathologic confirmed)", 
                                    "param": "Number", 
                                    "title": "Stent Thrombosis Rate (by Academic Research Consortium [ARC] Definitions)", 
                                    "units": "percentage of participants"
                                }
                            ]
                        }, 
                        "safety_issue": "Yes", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day and at 30 days", 
                        "title": "Stent Thrombosis Rate (by Academic Research Consortium [ARC] Definitions)", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Clinical procedural success is post-procedure diameter stenosis <30% in 2 near-orthogonal projections with TIMI 3 flow in all target lesions, as visually assessed by the physician, without the occurrence of in-hospital MI, TVR, or cardiac death.\nMI definition used was the PLATINUM definition for MI.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@lower_limit": "94.6", 
                                                    "@upper_limit": "100", 
                                                    "@value": "99"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Clinical procedural success is post-procedure diameter stenosis <30% in 2 near-orthogonal projections with TIMI 3 flow in all target lesions, as visually assessed by the physician, without the occurrence of in-hospital MI, TVR, or cardiac death.\nMI definition used was the PLATINUM definition for MI.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Number", 
                                    "title": "Clinical Procedural Success Rate", 
                                    "units": "percentage of participants"
                                }
                            ]
                        }, 
                        "safety_issue": "Yes", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day", 
                        "title": "Clinical Procedural Success Rate", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "As measured by an independent angiographic core laboratory using quantitative coronary angiography (QCA), the % diameter stenosis of the in-stent region.\nPercent diameter stenosis: Relative changes that occur in the percent diameter stenosis are provided by the following relationship: % diameter stenosis= (1-[Minimum Lumen Diameter/Reference diameter]) x 100.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "119"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Lesions analyzed", 
                                    "units": "Lesions"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "8.43", 
                                                    "@value": "3.86"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "As measured by an independent angiographic core laboratory using quantitative coronary angiography (QCA), the % diameter stenosis of the in-stent region.\nPercent diameter stenosis: Relative changes that occur in the percent diameter stenosis are provided by the following relationship: % diameter stenosis= (1-[Minimum Lumen Diameter/Reference diameter]) x 100.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "In-stent Percent Diameter Stenosis (%DS)", 
                                    "units": "In-Stent % Diameter Stenosis"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day", 
                        "title": "In-stent Percent Diameter Stenosis (%DS)", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "As measured by an independent angiographic core laboratory using quantitative coronary angiography (QCA),  the % diameter stenosis of the in-segment region (in-segment includes the stented region and 5 mm edge regions).\nPercent diameter stenosis: Relative changes that occur in the percent diameter stenosis are provided by the following relationship: % diameter stenosis= (1-[Minimum Lumen Diameter/Reference diameter]) x 100.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "119"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Lesions analyzed", 
                                    "units": "Lesions"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "7.9", 
                                                    "@value": "18.14"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "As measured by an independent angiographic core laboratory using quantitative coronary angiography (QCA),  the % diameter stenosis of the in-segment region (in-segment includes the stented region and 5 mm edge regions).\nPercent diameter stenosis: Relative changes that occur in the percent diameter stenosis are provided by the following relationship: % diameter stenosis= (1-[Minimum Lumen Diameter/Reference diameter]) x 100.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "In-segment Percent Diameter Stenosis (%DS)", 
                                    "units": "Diameter Stenosis, In-Segment (%)"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day", 
                        "title": "In-segment Percent Diameter Stenosis (%DS)", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "As measured by an independent angiographic core laboratory using quantitative coronary angiography (QCA); the minimum lumen diameter (MLD) measured at the in-stent region.\nThe MLD is the mean minimum lumen diameter (mm) from 2 orthogonal views.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "119"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Lesions analyzed", 
                                    "units": "Lesions"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "0.43", 
                                                    "@value": "2.69"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "As measured by an independent angiographic core laboratory using quantitative coronary angiography (QCA); the minimum lumen diameter (MLD) measured at the in-stent region.\nThe MLD is the mean minimum lumen diameter (mm) from 2 orthogonal views.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "In-stent Minimum Lumen Diameter (MLD)", 
                                    "units": "mm"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day", 
                        "title": "In-stent Minimum Lumen Diameter (MLD)", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "As measured by an independent angiographic core laboratory using quantitative coronary angiography (QCA); the minimum lumen diameter (MLD) measured at the in-segment region (in-segment includes the stented region and 5 mm edge regions).\nThe MLD is the mean minimum lumen diameter (mm) from 2 orthogonal views.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "119"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Lesions analyzed", 
                                    "units": "Lesions"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "0.46", 
                                                    "@value": "2.31"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "As measured by an independent angiographic core laboratory using quantitative coronary angiography (QCA); the minimum lumen diameter (MLD) measured at the in-segment region (in-segment includes the stented region and 5 mm edge regions).\nThe MLD is the mean minimum lumen diameter (mm) from 2 orthogonal views.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "In-segment Minimum Lumen Diameter (MLD)", 
                                    "units": "mm"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day", 
                        "title": "In-segment Minimum Lumen Diameter (MLD)", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Acute gain, as measured by angiographic core lab", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "0.45", 
                                                    "@value": "1.84"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Acute gain, as measured by angiographic core lab", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Acute Gain", 
                                    "units": "mm"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day", 
                        "title": "Acute Gain", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "As measured by IVUS, the mean vessel area (mm2).", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "99"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Lesions analyzed", 
                                    "units": "Lesions"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "4.34", 
                                                    "@value": "15.1"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "As measured by IVUS, the mean vessel area (mm2).", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Vessel Area", 
                                    "units": "mm^2"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day", 
                        "title": "Vessel Area", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "As measured by IVUS, the area of the stent.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "101"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Lesions analyzed", 
                                    "units": "Lesions"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "2.38", 
                                                    "@value": "7.83"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "As measured by IVUS, the area of the stent.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Stent Area", 
                                    "units": "mm^2"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day", 
                        "title": "Stent Area", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "As measured by IVUS, the area of the lumen.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Lesions analyzed", 
                                    "units": "Lesions"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "2.25", 
                                                    "@value": "7.76"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "As measured by IVUS, the area of the lumen.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Lumen Area", 
                                    "units": "mm^2"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day", 
                        "title": "Lumen Area", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "As measured by IVUS, the volume of the vessel.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "99"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Lesions analyzed", 
                                    "units": "Lesions"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "181.6", 
                                                    "@value": "354.34"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "As measured by IVUS, the volume of the vessel.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Vessel Volume", 
                                    "units": "mm^3"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day", 
                        "title": "Vessel Volume", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "As measured by IVUS, the volume of the stent.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "101"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Lesions analyzed", 
                                    "units": "Lesions"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "91.75", 
                                                    "@value": "185.3"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "As measured by IVUS, the volume of the stent.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Stent Volume", 
                                    "units": "mm^3"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day", 
                        "title": "Stent Volume", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "As measured by IVUS, the volume of the lumen.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Lesions analyzed", 
                                    "units": "Lesions"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": "87.93", 
                                                    "@value": "182.6"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "As measured by IVUS, the volume of the lumen.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Lumen Volume", 
                                    "units": "mm^3"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day", 
                        "title": "Lumen Volume", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Incomplete apposition rate, as measured by the IVUS core lab.\nBinary assessment of presence of one or more stent struts separated from the vessel wall as detected through intravascular ultrasound (IVUS).", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "101"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Lesions analyzed", 
                                    "units": "Lesions"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "12.9"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Incomplete apposition rate, as measured by the IVUS core lab.\nBinary assessment of presence of one or more stent struts separated from the vessel wall as detected through intravascular ultrasound (IVUS).", 
                                    "param": "Number", 
                                    "title": "Incomplete Apposition", 
                                    "units": "percentage of lesions"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day", 
                        "title": "Incomplete Apposition", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "The percentage of volume obstruction, as measured by the IVUS core lab.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Lesions analyzed", 
                                    "units": "Lesions"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@spread": ".01", 
                                                    "@value": "0"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "The percentage of volume obstruction, as measured by the IVUS core lab.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Percent Net Volume Obstruction", 
                                    "units": "% of volume"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day", 
                        "title": "Percent Net Volume Obstruction", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Longitudinal stent deformation, evidenced by longitudinal compression or elongation, as the result of crossing a newly deployed stent with a second device, (such as a balloon catheter, stent system or IVUS catheter), causing the second device to become caught on the stent when the second device is advanced or retracted.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                                "title": "NG PROMUS Stent"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "100"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "0"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Longitudinal stent deformation, evidenced by longitudinal compression or elongation, as the result of crossing a newly deployed stent with a second device, (such as a balloon catheter, stent system or IVUS catheter), causing the second device to become caught on the stent when the second device is advanced or retracted.", 
                                    "param": "Number", 
                                    "title": "Longitudinal Stent Deformation", 
                                    "units": "percentage of stents"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day", 
                        "title": "Longitudinal Stent Deformation", 
                        "type": "Secondary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": {
                        "@group_id": "P1", 
                        "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                        "title": "NG PROMUS Stent"
                    }
                }, 
                "period_list": {
                    "period": {
                        "drop_withdraw_reason_list": {
                            "drop_withdraw_reason": {
                                "participants_list": {
                                    "participants": {
                                        "@count": "1", 
                                        "@group_id": "P1"
                                    }
                                }, 
                                "title": "Death"
                            }
                        }, 
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "100", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "99", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "1", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }, 
                "recruitment_details": "Recruitment of subjects for NG PROMUS study started on November 20, 2012 and completed on March 12, 2013. Subjects were recruited at 9 investigational centers in Australia, New Zealand and Singapore."
            }, 
            "point_of_contact": {
                "email": "Peter.Maurer@bsci.com", 
                "name_or_title": "Peter Maurer, Director Clinical Trials", 
                "organization": "Boston Scientific", 
                "phone": "508-683-6678"
            }, 
            "reported_events": {
                "group_list": {
                    "group": {
                        "@group_id": "E1", 
                        "description": "Single-arm treatment group receiving interventional NG PROMUS study stent\nPercutaneous coronary intervention (NG PROMUS): Interventional coronary artery stenting with NG PROMUS study stent.", 
                        "title": "NG PROMUS Stent"
                    }
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "27", 
                                            "@subjects_at_risk": "100"
                                        }, 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@events": "16", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "16", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            "sub_title": "Myocardial infarction"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "5", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "5", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            "sub_title": "Coronary artery dissection"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            "sub_title": "Bradycardia"
                                        }
                                    ]
                                }, 
                                "title": "Cardiac disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@events": "1", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "100"
                                        }, 
                                        "sub_title": "Nausea"
                                    }
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@events": "3", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            "sub_title": "Catheter site haematoma"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            "sub_title": "Catheter site haemorrhage"
                                        }
                                    ]
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            "sub_title": "Procedural hypotension"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            "sub_title": "Skin laceration"
                                        }
                                    ]
                                }, 
                                "title": "Injury, poisoning and procedural complications"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@events": "1", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "100"
                                        }, 
                                        "sub_title": "Blood urine present"
                                    }
                                }, 
                                "title": "Investigations"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            "sub_title": "Muscle spasms"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            "sub_title": "Musculoskeletal pain"
                                        }
                                    ]
                                }, 
                                "title": "Musculoskeletal and connective tissue disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@events": "2", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "2", 
                                            "@subjects_at_risk": "100"
                                        }, 
                                        "sub_title": "Presyncope"
                                    }
                                }, 
                                "title": "Nervous system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@events": "1", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "100"
                                        }, 
                                        "sub_title": "Increased tendency to bruise"
                                    }
                                }, 
                                "title": "Skin and subcutaneous tissue disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment", 
                    "default_vocab": "MedDRA (12.1)", 
                    "frequency_threshold": "1"
                }, 
                "serious_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "16", 
                                            "@subjects_at_risk": "100"
                                        }, 
                                        "sub_title": "Total, serious adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@events": "4", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "4", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            "sub_title": "Coronary artery dissection"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            "sub_title": "Atrial fibrillation"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            "sub_title": "Cardiac arrest"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            "sub_title": "Coronary artery stenosis"
                                        }, 
                                        {
                                            "counts": {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "100"
                                            }, 
                                            "sub_title": "Pericarditis"
                                        }
                                    ]
                                }, 
                                "title": "Cardiac disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@events": "7", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "7", 
                                            "@subjects_at_risk": "100"
                                        }, 
                                        "sub_title": "Non-cardiac chest pain"
                                    }
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@events": "1", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "100"
                                        }, 
                                        "sub_title": "Pneumonia"
                                    }
                                }, 
                                "title": "Infections and infestations"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@events": "1", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "100"
                                        }, 
                                        "sub_title": "Vascular pseudoaneurysm"
                                    }
                                }, 
                                "title": "Injury, poisoning and procedural complications"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@events": "1", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "100"
                                        }, 
                                        "sub_title": "Costochondritis"
                                    }
                                }, 
                                "title": "Musculoskeletal and connective tissue disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment", 
                    "default_vocab": "MedDRA (12.1)"
                }, 
                "time_frame": "Serious and non-serious adverse events were collected from the point of subject enrollment through study completion at 30 days."
            }
        }, 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Atherosclerosis", 
            "Coronary Artery Disease"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Atherosclerosis", 
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "To evaluate clinical and peri-procedural angiographic and intravascular ultrasound (IVUS)\n      outcomes for the NG PROMUS Everolimus-Eluting Platinum Chromium Coronary Stent System (NG\n      PROMUS Stent System) in the treatment of subjects with atherosclerotic lesion(s) \u2264 34 mm in\n      length (by visual estimate) in native coronary arteries \u2265 2.50 mm to \u2264 4.0 mm in diameter\n      (by visual estimate)"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Clinical Inclusion Criteria:\n\n          1. Subject must be at least 18 years of age\n\n          2. Subject (or legal guardian) understands the trial requirements and the treatment\n             procedures and provides written informed consent before any trial-specific tests or\n             procedures are performed\n\n          3. Subject is eligible for percutaneous coronary intervention (PCI)\n\n          4. Subject has symptomatic coronary artery disease with objective evidence of ischemia\n             or silent ischemia\n\n          5. Subject is an acceptable candidate for coronary artery bypass grafting (CABG)\n\n          6. Subject is willing to comply with all protocol-required follow-up evaluation\n\n        Angiographic Inclusion Criteria:\n\n          1. Target lesion(s) must be located in a native coronary artery with a visually\n             estimated reference vessel diameter (RVD) \u22652.50 mm and \u22644.0 mm\n\n          2. Target lesion(s) length must be \u226434 mm (by visual estimate)\n\n          3. Target lesion(s) must have visually estimated stenosis \u226550% and <100% with\n             thrombolysis in Myocardial Infarction (TIMI) flow >1 and one of the following\n             (stenosis \u226570%, abnormal fractional flow reserve (FFR), abnormal stress test or\n             imaging stress test, or elevated biomarkers) prior to procedure\n\n          4. Coronary anatomy is likely to allow delivery of a study device to the target\n             lesions(s)\n\n          5. The first lesion treated must be successfully pre-dilated/pretreated Note:\n             Successful pre-dilatation/pretreatment refers to dilatation with a balloon catheter\n             of appropriate length and diameter, or pretreatment with directional or rotational\n             coronary atherectomy, laser or cutting/scoring balloon with no greater than 50%\n             residual stenosis and no dissection greater than National Heart, Lung, Blood\n             Institute (NHLBI) type C.\n\n        Clinical Exclusion Criteria:\n\n          1. Subject has clinical symptoms and/or electrocardiogram (ECG) changes consistent with\n             acute ST elevation MI (STEMI)\n\n          2. Subject has cardiogenic shock, hemodynamic instability requiring inotropic or\n             mechanical circulatory support, intractable ventricular arrhythmias, or ongoing\n             intractable angina\n\n          3. Subject has received an organ transplant or is on a waiting list for an organ\n             transplant\n\n          4. Subject is receiving or scheduled to receive chemotherapy within 30 days before or\n             after the index procedure\n\n          5. Planned PCI (including staged procedures) or CABG after the index procedure\n\n          6. Subject previously treated at any time with intravascular brachytherapy\n\n          7. Subject has a known allergy to contrast (that cannot be adequately premedicated)\n             and/or the trial stent system or protocol-required concomitant medications (e.g.,\n             platinum, platinum-chromium alloy, stainless steel, everolimus or structurally\n             related compounds, polymer or individual components, all P2Y12 inhibitors, or\n             aspirin)\n\n          8. Subject has one of the following (as assessed prior to the index procedure):Other\n             serious medical illness (e.g., cancer, congestive heart failure) with estimated life\n             expectancy of less than 24 months; Current problems with substance abuse (e.g.,\n             alcohol, cocaine, heroin, etc.);Planned procedure that may cause non-compliance with\n             the protocol or confound data interpretation\n\n          9. Subject is receiving chronic (\u226572 hours) anticoagulation therapy (i.e., heparin,\n             coumadin) for indications other than acute coronary syndrome\n\n         10. Subject has a platelet count <100,000 cells/mm3 or >700,000 cells/mm3\n\n         11. Subject has a white blood cell (WBC) count < 3,000 cells/mm3\n\n         12. Subject has documented or suspected liver disease, including laboratory evidence of\n             hepatitis\n\n         13. Subject is on dialysis or has baseline serum creatinine level >2.0 mg/dL (177\u00b5mol/L)\n\n         14. Subject has a history of bleeding diathesis or coagulopathy or will refuse blood\n             transfusions\n\n         15. Subject has had a history of cerebrovascular accident (CVA) or transient ischemic\n             attack (TIA) within the past 6 months\n\n         16. Subject has an active peptic ulcer or active gastrointestinal (GI) bleeding\n\n         17. Subject has signs or symptoms of active heart failure (i.e., NYHA class IV) at the\n             time of the index procedure\n\n         18. Subject is participating in another investigational drug or device clinical trial\n             that has not reached its primary endpoint\n\n         19. Subject intends to participate in another investigational drug or device clinical\n             trial within 12 months after the index procedure\n\n         20. Subject with known intention to procreate within 12 months after the index procedure\n             (women of child-bearing potential who are sexually active must agree to use a\n             reliable method of contraception from the time of screening through 12 months after\n             the index procedure)\n\n         21. Subject is a woman who is pregnant or nursing (a pregnancy test must be performed\n             within 7 days prior to the index procedure in women of child-bearing potential)\n\n        Angiographic Exclusion Criteria:\n\n          1. Planned treatment of more than 3 lesions.\n\n          2. Planned treatment of lesions in more than 2 major epicardial vessels\n\n          3. Planned treatment of a single lesion with more than 1 stent\n\n          4. Subject has 2 target lesions in the same vessel that are separated by less than 15 mm\n             (by visual estimate)\n\n          5. Target lesion(s) is located in the left main\n\n          6. Target lesion(s) is located within 3 mm of the origin of the left anterior descending\n             (LAD) coronary artery or left circumflex (LCx) coronary artery by visual estimate.\n\n          7. Target lesion(s) is located within a saphenous vein graft or an arterial graft\n\n          8. Target lesion(s) will be accessed via a saphenous vein graft or arterial graft\n\n          9. Target lesion(s) with a TIMI flow 0 (total occlusion) or TIMI flow 1 prior  to guide\n             wire crossing\n\n         10. Target lesion(s) treated during the index procedure that involves a complex\n             bifurcation (e.g., bifurcation lesion requiring treatment with more than 1 stent)\n\n         11. Target lesion(s) is restenotic from a previous stent implantation or study stent\n             would overlap with a previous stent\n\n         12. Subject has unprotected left main coronary artery disease (>50% diameter stenosis)\n\n         13. Subject has been treated with any type of PCI (i.e., balloon angioplasty, stent,\n             cutting balloon atherectomy) within 24 hours prior to the index procedure\n\n         14. Thrombus, or possible thrombus, present in the target vessel (by visual estimate)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 5, 2012", 
        "firstreceived_results_date": "December 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01703000", 
            "org_study_id": "NG PROMUS Clinical Trial S2294"
        }, 
        "intervention": {
            "arm_group_label": "NG PROMUS stent", 
            "description": "Interventional coronary artery stenting with NG PROMUS study stent.", 
            "intervention_name": "Percutaneous coronary intervention (NG PROMUS)", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "drug eluting coronary stent", 
        "lastchanged_date": "March 20, 2014", 
        "link": {
            "description": "Drug-eluting product information from Manufacturer", 
            "url": "http://www.pharma.us.novartis.com/info/products/name/zortress.jsp"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Fremantle", 
                        "country": "Australia", 
                        "state": "Western Australia", 
                        "zip": "6160"
                    }, 
                    "name": "Fremantle Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Auckland", 
                        "country": "New Zealand", 
                        "zip": "1003"
                    }, 
                    "name": "Mercy Angiography Unit, Ltd. Mercy Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Auckland", 
                        "country": "New Zealand", 
                        "zip": "1010"
                    }, 
                    "name": "Auckland City Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Auckland", 
                        "country": "New Zealand", 
                        "zip": "1030"
                    }, 
                    "name": "North Shore Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Auckland", 
                        "country": "New Zealand", 
                        "zip": "1546"
                    }, 
                    "name": "Ascot Angiography"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Christchurch", 
                        "country": "New Zealand", 
                        "zip": "8140"
                    }, 
                    "name": "Christchurch"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Otahuhu", 
                        "country": "New Zealand", 
                        "zip": "1640"
                    }, 
                    "name": "Middlemore Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Singapore", 
                        "country": "Singapore", 
                        "zip": "168752"
                    }, 
                    "name": "National Heart Center Singapore"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Singapore", 
                        "country": "Singapore", 
                        "zip": "119228"
                    }, 
                    "name": "National University Hospital Singapore"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Australia", 
                "New Zealand", 
                "Singapore"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "NG PROMUS: A Prospective, Multicenter Trial to Assess the NG PROMUS Everolimus-Eluting Platinum Chromium Coronary Stent System (NG PROMUS Stent System) for the Treatment of Atherosclerotic Lesion(s)", 
        "overall_official": {
            "affiliation": "Mercy Angiography Unit, Ltd. Mercy Hospital", 
            "last_name": "John A Ormiston, MBChB, FRACP, FRACR", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Singapore: Health Sciences Authority", 
                "Australia: Department of Health and Ageing Therapeutic Goods Administration", 
                "New Zealand: Medsafe - Medicines and Medical Devices Safety Authority"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Technical success is defined as successful delivery and deployment of the study stent to the target lesion, without balloon rupture or stent embolization, and post-procedure diameter stenosis of <30% assessed in 2 near-orthogonal projections with TIMI 3 flow in the target lesion, as visually assessed by the physician", 
            "measure": "Technical Success Rate", 
            "safety_issue": "Yes", 
            "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01703000"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Target lesion revascularization is any ischemia-driven repeat percutaneous intervention, to improve blood flow, of the successfully treated target lesion or bypass surgery of the target vessel with a graft distally to the successfully treated target lesion. A TLR will be considered as ischemia-driven if the target lesion diameter stenosis is >/= 50% by QCA and there is presence of clinical or functional ischemia which cannot be explained by other coronary or graft lesions. Clinical or functional ischemia is any of the following:\nThe subject has a positive functional study corresponding to the area served by the target lesion.\nThe subject has ischemic ECG changes at rest in a distribution consistent with the target vessel.\nThe subject has ischemic symptoms referable to the target lesion. A TLR will be considered as ischemia-driven if the lesion diameter stenosis is >/= 70% by QCA even in the absence of clinical or functional ischemia.", 
                "measure": "Target Lesion Revascularization (TLR) Rate", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day and at 30 days"
            }, 
            {
                "description": "Target lesion failure is any ischemia-driven revascularization of the target lesion, MI (Q-wave and non-Q-wave) related to the target vessel, or (cardiac) death. For the purposes of this protocol, if it cannot be determined with certainty whether the MI was related to the target vessel, it will be considered a TLF.\nThe MI definition used for Target Lesion Failure was the PLATINUM MI definition.", 
                "measure": "Target Lesion Failure (TLF) Rate", 
                "safety_issue": "Yes", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day and at 30 days"
            }, 
            {
                "description": "Target vessel revascularization is defined as a TLR or a TVR remote. Target vessel revascularization remote is any ischemia-driven repeat percutaneous intervention, to improve blood flow, or bypass surgery of not previously existing lesions diameter stenosis >/= 50% by QCA in the target vessel, excluding the target lesion. A TVR will be considered ischemia-driven if the target vessel diameter stenosis is >/= 50% by QCA and any of the following are present:\nThe subject has a positive functional study corresponding to the area served by the target vessel.\nThe subject has ischemic ECG changes at rest in a distribution consistent with the target vessel.\nThe subject has ischemic symptoms referable to the target vessel. A TVR will also be considered as ischemia-driven if the lesion diameter stenosis is >/=70% even in the absence of clinical or functional ischemia.", 
                "measure": "Target Vessel Revascularization (TVR) Rate", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day and at 30 days"
            }, 
            {
                "description": "Target vessel failure is any ischemia-driven revascularization of the target vessel, MI (Q-wave and non-Q-wave) related to the target vessel or death related to the target vessel. For the purposes of this protocol, if it cannot be determined with certainty whether the MI or death was related to the target vessel, it will be considered a TVF.\nThe MI definition used was the PLATINUM MI definition.", 
                "measure": "Target Vessel Failure (TVF) Rate", 
                "safety_issue": "Yes", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day and at 30 days"
            }, 
            {
                "description": "MI will be defined according to the PLATINUM Definition of MI with evidence pre-specified for i) Spontaneous, ii) PCI-related, iii) CABG related, and iv) autopsy evidence criteria.", 
                "measure": "Myocardial Infarction (MI, Q-wave and Non-Q-wave) Rate", 
                "safety_issue": "Yes", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day and at 30 days"
            }, 
            {
                "description": "Cardiac death is defined as death due to any of the following.\nAcute MI\nCardiac perforation/pericardial tamponade\nArrhythmia or conduction abnormality\nCVA through hospital discharge or CVA suspected of being related to the procedure\nDeath due to complication of the procedure, including bleeding, vascular repair, transfusion reaction, or bypass surgery\nAny death in which a cardiac cause cannot be excluded", 
                "measure": "Cardiac Death Rate", 
                "safety_issue": "Yes", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day and at 30 days"
            }, 
            {
                "description": "Non-cardiac death is defined as a death not due to any of the following:\nAcute MI\nCardiac perforation/pericardial tamponade\nArrhythmia or conduction abnormality\nCVA through hospital discharge or CVA suspected of being related to the procedure\nDeath due to complication of the procedure, including bleeding, vascular repair, transfusion reaction, or bypass surgery\nAny death in which a cardiac cause cannot be excluded", 
                "measure": "Non-cardiac Death Rate", 
                "safety_issue": "Yes", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day and at 30 days"
            }, 
            {
                "description": "Death is categorized as cardiac or non-cardiac deaths.", 
                "measure": "All Death Rate", 
                "safety_issue": "Yes", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day and at 30 days"
            }, 
            {
                "description": "Any cardiac death or MI event meeting the criteria defined for a cardiac death or MI.\nMI definition used was the PLATINUM definition for MI.", 
                "measure": "Cardiac Death or MI Rate", 
                "safety_issue": "Yes", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day and at 30 days"
            }, 
            {
                "description": "Any all-cause mortality event or MI meeting the criteria defined for any death or MI.\nMI definition used was the PLATINUM definition for MI.", 
                "measure": "All Death or MI Rate", 
                "safety_issue": "Yes", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day and at 30 days"
            }, 
            {
                "description": "Any event meeting the pre-specified criteria for any death, MI, or TVR.\nMI definition used was the PLATINUM definition for MI.", 
                "measure": "All Death/MI/TVR Rate", 
                "safety_issue": "Yes", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day and at 30 days"
            }, 
            {
                "description": "Stent thrombosis should be reported as a cumulative value at the different time points and with the different separate time points. Time 0 is defined as the time point after the guide catheter has been removed and the patient left the catheterization lab.\nTiming:\nAcute stent thrombosis*: 0 24 hours after stent implantation\nSubacute stent thrombosis*: >24 hours to 30 days after stent implantation\nLate stent thrombosis: >30 days to 1 year after stent implantation\nVery late stent thrombosis: >1 year after stent implantation * Acute/subacute can also be replaced by early stent thrombosis. Early stent thrombosis is 0 30 days.\nStent thrombosis may be defined as:\nConfirmed/definite\nProbable\nPossible\nConfirmed/Definite (is considered either angiographic confirmed or pathologic confirmed)", 
                "measure": "Stent Thrombosis Rate (by Academic Research Consortium [ARC] Definitions)", 
                "safety_issue": "Yes", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day and at 30 days"
            }, 
            {
                "description": "Clinical procedural success is post-procedure diameter stenosis <30% in 2 near-orthogonal projections with TIMI 3 flow in all target lesions, as visually assessed by the physician, without the occurrence of in-hospital MI, TVR, or cardiac death.\nMI definition used was the PLATINUM definition for MI.", 
                "measure": "Clinical Procedural Success Rate", 
                "safety_issue": "Yes", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day"
            }, 
            {
                "description": "As measured by an independent angiographic core laboratory using quantitative coronary angiography (QCA), the % diameter stenosis of the in-stent region.\nPercent diameter stenosis: Relative changes that occur in the percent diameter stenosis are provided by the following relationship: % diameter stenosis= (1-[Minimum Lumen Diameter/Reference diameter]) x 100.", 
                "measure": "In-stent Percent Diameter Stenosis (%DS)", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day"
            }, 
            {
                "description": "As measured by an independent angiographic core laboratory using quantitative coronary angiography (QCA),  the % diameter stenosis of the in-segment region (in-segment includes the stented region and 5 mm edge regions).\nPercent diameter stenosis: Relative changes that occur in the percent diameter stenosis are provided by the following relationship: % diameter stenosis= (1-[Minimum Lumen Diameter/Reference diameter]) x 100.", 
                "measure": "In-segment Percent Diameter Stenosis (%DS)", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day"
            }, 
            {
                "description": "As measured by an independent angiographic core laboratory using quantitative coronary angiography (QCA); the minimum lumen diameter (MLD) measured at the in-stent region.\nThe MLD is the mean minimum lumen diameter (mm) from 2 orthogonal views.", 
                "measure": "In-stent Minimum Lumen Diameter (MLD)", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day"
            }, 
            {
                "description": "As measured by an independent angiographic core laboratory using quantitative coronary angiography (QCA); the minimum lumen diameter (MLD) measured at the in-segment region (in-segment includes the stented region and 5 mm edge regions).\nThe MLD is the mean minimum lumen diameter (mm) from 2 orthogonal views.", 
                "measure": "In-segment Minimum Lumen Diameter (MLD)", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day"
            }, 
            {
                "description": "Acute gain, as measured by angiographic core lab", 
                "measure": "Acute Gain", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day"
            }, 
            {
                "description": "As measured by IVUS, the mean vessel area (mm2).", 
                "measure": "Vessel Area", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day"
            }, 
            {
                "description": "As measured by IVUS, the area of the stent.", 
                "measure": "Stent Area", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day"
            }, 
            {
                "description": "As measured by IVUS, the area of the lumen.", 
                "measure": "Lumen Area", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day"
            }, 
            {
                "description": "As measured by IVUS, the volume of the vessel.", 
                "measure": "Vessel Volume", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day"
            }, 
            {
                "description": "As measured by IVUS, the volume of the stent.", 
                "measure": "Stent Volume", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day"
            }, 
            {
                "description": "As measured by IVUS, the volume of the lumen.", 
                "measure": "Lumen Volume", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day"
            }, 
            {
                "description": "Incomplete apposition rate, as measured by the IVUS core lab.\nBinary assessment of presence of one or more stent struts separated from the vessel wall as detected through intravascular ultrasound (IVUS).", 
                "measure": "Incomplete Apposition", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day"
            }, 
            {
                "description": "The percentage of volume obstruction, as measured by the IVUS core lab.", 
                "measure": "Percent Net Volume Obstruction", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day"
            }, 
            {
                "description": "Longitudinal stent deformation, evidenced by longitudinal compression or elongation, as the result of crossing a newly deployed stent with a second device, (such as a balloon catheter, stent system or IVUS catheter), causing the second device to become caught on the stent when the second device is advanced or retracted.", 
                "measure": "Longitudinal Stent Deformation", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 day"
            }
        ], 
        "source": "Boston Scientific Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Boston Scientific Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}